- Corporate Officers - R
- Rhodes Jennifer J
Insider Trading History of Rhodes Jennifer J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rhodes Jennifer J since 2015.
This trader's CIK number is 1568249.
At the time of last reporting, Rhodes Jennifer J was the EVP, CHIEF LEGAL OFFICER, SEC of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
Note that in the past
Rhodes Jennifer J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Medivation, Inc. (MDVN) by Rhodes Jennifer J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | MDVN | 0 | $0 | 4,000 | $487,496 | 2,000 | $94,960 |
Yearly summary of insider trading at Adamas Pharmaceuticals Inc (ADMS) by Rhodes Jennifer J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ADMS | 0 | $0 | 2,732 | $19,347 | 0 | $0 |
| 2018 | ADMS | 0 | $0 | 2,409 | $54,149 | 0 | $0 |
| 2017 | ADMS | 0 | $0 | 1,481 | $32,464 | 0 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Rhodes Jennifer J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | ACAD | 0 | $0 | 6,950 | $162,491 | 12,944 | $0 |
Yearly summary of insider trading at Elicio Therapeutics, Inc. (ANGN) by Rhodes Jennifer J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ANGN | 0 | $0 | 5,274 | $62,423 | 0 | $0 |
Insider trading activities at 4 companies by Rhodes Jennifer J:
1. Medivation, Inc. (MDVN)
2. Adamas Pharmaceuticals Inc (ADMS)
3. Acadia Pharmaceuticals Inc (ACAD)
4. Elicio Therapeutics, Inc. (ANGN)
Table 1. Insider trading of Medivation, Inc. (MDVN) by Rhodes Jennifer J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-16 | MDVN | Sale | 1,390 | 130.92 | 181,978 |
| 2015-03-02 | MDVN | Option Ex | 2,000 | 47.48 | 94,960 |
| 2015-03-02 | MDVN | Sale | 2,000 | 122.00 | 244,000 |
| 2015-02-04 | MDVN | Sale | 610 | 100.85 | 61,518 |
Table 2. Insider trading of Adamas Pharmaceuticals Inc (ADMS) by Rhodes Jennifer J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-20 | ADMS | Sale | 940 | 5.35 | 5,029 |
| 2019-03-20 | ADMS | Sale | 1,792 | 7.99 | 14,318 |
| 2018-12-20 | ADMS | Sale | 425 | 7.52 | 3,196 |
| 2018-06-21 | ADMS | Sale | 1,002 | 25.48 | 25,530 |
| 2018-03-21 | ADMS | Sale | 982 | 25.89 | 25,423 |
| 2017-12-21 | ADMS | Sale | 440 | 32.30 | 14,211 |
| 2017-06-21 | ADMS | Sale | 1,041 | 17.54 | 18,253 |
Table 3. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Rhodes Jennifer J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-02-09 | ACAD | Sale | 6,950 | 23.38 | 162,491 |
| 2026-02-06 | ACAD | Option Ex | 12,944 | .00 | 0 |
Table 4. Insider trading of Elicio Therapeutics, Inc. (ANGN) by Rhodes Jennifer J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-14 | ANGN | Sale | 451 | 2.42 | 1,090 |
| 2021-11-15 | ANGN | Sale | 433 | 4.40 | 1,905 |
| 2021-10-14 | ANGN | Sale | 430 | 8.65 | 3,719 |
| 2021-09-14 | ANGN | Sale | 430 | 10.64 | 4,575 |
| 2021-08-16 | ANGN | Sale | 445 | 10.68 | 4,752 |
| 2021-07-21 | ANGN | Sale | 432 | 10.94 | 4,726 |
| 2021-07-14 | ANGN | Sale | 431 | 11.01 | 4,745 |
| 2021-06-14 | ANGN | Sale | 427 | 13.27 | 5,666 |
| 2021-05-14 | ANGN | Sale | 440 | 13.92 | 6,124 |
| 2021-04-15 | ANGN | Sale | 399 | 15.01 | 5,988 |
| 2021-03-13 | ANGN | Sale | 499 | 20.45 | 10,204 |
| 2021-02-13 | ANGN | Sale | 457 | 19.54 | 8,929 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rhodes Jennifer J
(EVP, CHIEF LEGAL OFFICER, SEC of Acadia Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.